Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.

Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.

OBJECTIVES: Whether the duration of maintenance treatment with azathioprine (AZA) affects the outcome of ulcerative colitis (UC) is unclear. We investigated clinical outcomes and any predictive factors after withdrawal of AZA in UC. METHODS: In this multicenter observational retrospective study, 12...

Description complète

Détails bibliographiques
Auteurs principaux:	Cassinotti, A, Actis, G, Duca, P, Massari, A, Colombo, E, Gai, E, Annese, V, D'Albasio, G, Manes, G, Travis, S, Porro, G, Ardizzone, S
Format:	Journal article
Langue:	English
Publié:	2009

Documents similaires

Azathioprine in ulcerative colitis.
par: Jewell, D, et autres
Publié: (1972)

IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit tool.
par: Cassinotti, A, et autres
Publié: (2009)

Azathioprine-Induced Pericarditis in a Patient with Ulcerative Colitis
par: C David Simpson
Publié: (1997-01-01)

Alopecia Universalis Associated with Ulcerative Colitis and The Role of Azathioprine
par: Kyrillus S Shohdy, et autres
Publié: (2018-01-01)

Azathioprine in ulcerative colitis: final report on controlled therapeutic trial.
par: Jewell, D, et autres
Publié: (1974)

Azathioprine in ulcerative colitis: an interim report on a controlled therapeutic trial.
par: Jewell, D, et autres
Publié: (1972)

Review: Immunomodulators for all patients with inflammatory bowel disease?
par: Sandro Ardizzone, et autres
Publié: (2010-01-01)

Evaluation of low doses of Azathioprine in reducing relapse and corticosteroid dependence in patients with Ulcerative Colitis
par: Maryam Rezaiee, et autres
Publié: (2019-05-01)

Modified Kudo classification can improve accuracy of virtual chromoendoscopy with FICE in endoscopic surveillance of ulcerative colitis
par: Andrea Cassinotti, et autres
Publié: (2020-09-01)

Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial
par: Marianne Kiszka-Kanowitz, et autres
Publié: (2022-03-01)

Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients
par: Tong Li, et autres
Publié: (2020-11-01)

6-Mercaptopurine Or Azathioprine?
par: McGovern, D, et autres
Publié: (2007)

Biologics for Ulcerative Colitis: Status of the Art and General Considerations
par: Giovanni Clemente Actis
Publié: (2017-03-01)

Infliximab and azathioprine: bridge or parachute?
par: Travis, S
Publié: (2006)

Granulocyte-Monocyte Apheresis in Steroid-Dependent, Azathioprine-Intolerant/Resistant Moderate Ulcerative Colitis: A Prospective Multicenter Study
par: Gianni Imperiali, et autres
Publié: (2017-01-01)

A rare case report: Myopathy related to the interaction between azathioprine and infliximab in the treatment of ulcerative colitis and ankylosing spondylitis
par: Lingyu Fu, et autres
Publié: (2024-06-01)

Adalimumab for the treatment of Crohn&rsquo;s disease
par: Andrea Cassinotti, et autres
Publié: (2008-09-01)

Intensification of maintenance therapy with infliximab in ulcerative colitis
par: Francesc Casellas

Infliximab treatment in a paediatric patient with ulcerative colitis, who developed acute pancreatitis due to azathioprine during follow-up
par: Ahmet Basturk, et autres
Publié: (2017-09-01)

Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
par: Maconi G, et autres
Publié: (2021-04-01)

The European consensus on ulcerative colitis: new horizons?
par: Stange, E, et autres
Publié: (2008)

Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis.
par: Campbell, A, et autres
Publié: (1976)

Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis
par: Jairath, V, et autres
Publié: (2017)

Review article: maintenance therapy in patients with ulcerative colitis.
par: Orchard, T, et autres
Publié: (2006)

Predicting outcome in severe ulcerative colitis.
par: Travis, S
Publié: (2004)

Ulcerative colitis and sarcoidosis.
par: Barr, G, et autres
Publié: (1986)

Insights into the role of gastrointestinal ultrasound in ulcerative colitis
par: Cristina Bezzio, et autres
Publié: (2021-10-01)

Salicylates for ulcerative colitis--their mode of action.
par: Travis, S, et autres
Publié: (1994)

Therapy of ulcerative colitis: state of the art.
par: Brain, O, et autres
Publié: (2008)

Maintenance of efficacy following tofacitinib dose reduction in patients with ulcerative colitis in stable remission
par: Rubin, D, et autres
Publié: (2019)

Rapid Induction and Maintenance of Remission in Refractory Ulcerative Colitis with Ustekinumab
par: An-Yu Chen, et autres
Publié: (2019-09-01)

Therapeutic landscape for ulcerative colitis: where is the Adacolumn&reg; system and where should it be?
par: D&rsquo;Inc&agrave; R, et autres
Publié: (2013-01-01)

MESALAZINE PLACE IN THERAPY OF ULCERATIVE COLITIS
par: I. G. Bakulin, et autres
Publié: (2017-11-01)

Expression of lectins in nonspecific ulcerative colitis
par: Maslyakova G.N., et autres
Publié: (2012-12-01)

Comparing disease activity indices in ulcerative colitis
par: Walsh, A, et autres
Publié: (2014)

Comparing disease activity indices in ulcerative colitis.
par: Walsh, A, et autres
Publié: (2014)

Optimum dose of olsalazine for maintaining remission in ulcerative colitis.
par: Travis, S, et autres
Publié: (1994)

Azathioprine and Steroids
par: Knight, SR, et autres
Publié: (2008)

Oral methotrexate in ulcerative colitis.
par: Cummings, JR, et autres
Publié: (2005)

Assessing disease activity in patients with ulcerative colitis.
par: Walsh, A, et autres
Publié: (2012)